• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以[Sc]Sc-PSMA-617 和 [Sc]Sc-PSMA-I&T 合成为例的放射性药物制备用发生器系统中 Sc 与 Ti 的分离。

Separation of Sc from Ti in the Context of A Generator System for Radiopharmaceutical Purposes with the Example of [Sc]Sc-PSMA-617 and [Sc]Sc-PSMA-I&T Synthesis.

机构信息

State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Zhivopisnaya Str., bld. 46, 123098 Moscow, Russia.

出版信息

Molecules. 2021 Oct 21;26(21):6371. doi: 10.3390/molecules26216371.

DOI:10.3390/molecules26216371
PMID:34770780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8587778/
Abstract

Today, Sc is an attractive radionuclide for molecular imaging with PET. In this work, we evaluated a Ti/Sc radionuclide generator based on TEVA resin as a source of Sc. The generator prototype (5 MBq) exhibits high Ti retention and stable yield of Sc (91 ± 6 %) in 1 mL of eluate (20 bed volumes, eluent-0.1 M oxalic acid/0.2 M HCl) during one year of monitoring (more than 120 elutions). The breakthrough of Ti did not exceed 1.5 × 10% (average value was 6.5 × 10%). Post-processing of the eluate for further use in radiopharmaceutical synthesis was proposed. The post-processing procedure using a combination of Presep PolyChelate and TK221 resins made it possible to obtain Sc-radioconjugates with high labeling yield (≥95%) while using small precursor amounts (5 nmol). The proposed method takes no more than 15 min and provides ≥90% yield relative to the Sc activity eluted from the generator. The labeling efficiency was demonstrated on the example of [Sc]Sc-PSMA-617 and [Sc]Sc-PSMA-I&T synthesis. Some superiority of PSMA-I&T over PSMA-617 in terms of Sc labeling efficiency was demonstrated (likely due to presence of DOTAGA chelator in the precursor structure). It was also shown that microwave heating of the reaction mixture considerably shortened the reaction time and improved radiolabeling yield and reproducibility of [Sc]Sc-PSMA-617 and [Sc]Sc-PSMA-I&T synthesis.

摘要

今天,Sc 是用于 PET 分子成像的有吸引力的放射性核素。在这项工作中,我们评估了一种基于 TEVA 树脂的 Ti/Sc 放射性核素发生器,作为 Sc 的来源。在一年的监测期间(超过 120 次洗脱),该发生器原型(5 MBq)在 1 mL 洗脱液(20 床体积,洗脱液-0.1 M 草酸/0.2 M HCl)中表现出高钛保留率和稳定的 Sc 产率(91±6%)。Ti 的突破不超过 1.5×10%(平均值为 6.5×10%)。提出了对洗脱液进行后处理以进一步用于放射性药物合成的方法。使用 Presep PolyChelate 和 TK221 树脂的组合进行后处理程序,可以在使用少量前体(5 nmol)的情况下获得具有高标记产率(≥95%)的 Sc 放射性缀合物。该方法不超过 15 分钟,与从发生器洗脱的 Sc 活性相比,提供≥90%的产率。通过[Sc]Sc-PSMA-617 和[Sc]Sc-PSMA-I&T 合成的实例证明了标记效率。在 Sc 标记效率方面,PSMA-I&T 相对于 PSMA-617 具有一些优势(可能是由于前体结构中存在 DOTAGA 螯合剂)。还表明,反应混合物的微波加热大大缩短了反应时间,并提高了[Sc]Sc-PSMA-617 和[Sc]Sc-PSMA-I&T 合成的放射性标记产率和重现性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/a73404448f5b/molecules-26-06371-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/db53265df370/molecules-26-06371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/87382e6b998f/molecules-26-06371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/ae82625b2b71/molecules-26-06371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/cc8d5961ebf8/molecules-26-06371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/e81010604e0f/molecules-26-06371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/16a3b1f2e15b/molecules-26-06371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/ec5b3d159186/molecules-26-06371-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/18bd936aab36/molecules-26-06371-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/9369df744106/molecules-26-06371-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/57a0ab2eb563/molecules-26-06371-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/c02d762c5f01/molecules-26-06371-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/b77b1ac3efc7/molecules-26-06371-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/a73404448f5b/molecules-26-06371-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/db53265df370/molecules-26-06371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/87382e6b998f/molecules-26-06371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/ae82625b2b71/molecules-26-06371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/cc8d5961ebf8/molecules-26-06371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/e81010604e0f/molecules-26-06371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/16a3b1f2e15b/molecules-26-06371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/ec5b3d159186/molecules-26-06371-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/18bd936aab36/molecules-26-06371-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/9369df744106/molecules-26-06371-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/57a0ab2eb563/molecules-26-06371-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/c02d762c5f01/molecules-26-06371-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/b77b1ac3efc7/molecules-26-06371-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/754a/8587778/a73404448f5b/molecules-26-06371-g013.jpg

相似文献

1
Separation of Sc from Ti in the Context of A Generator System for Radiopharmaceutical Purposes with the Example of [Sc]Sc-PSMA-617 and [Sc]Sc-PSMA-I&T Synthesis.以[Sc]Sc-PSMA-617 和 [Sc]Sc-PSMA-I&T 合成为例的放射性药物制备用发生器系统中 Sc 与 Ti 的分离。
Molecules. 2021 Oct 21;26(21):6371. doi: 10.3390/molecules26216371.
2
Post-elution processing of (44)Ti/(44)Sc generator-derived (44)Sc for clinical application.用于临床应用的由(44)Ti/(44)Sc发生器产生的(44)Sc的洗脱后处理。
Appl Radiat Isot. 2010 Sep;68(9):1636-41. doi: 10.1016/j.apradiso.2010.04.003. Epub 2010 Apr 24.
3
Clinical Translation and First In-Human Use of [Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.[钪]Sc-PSMA-617用于转移性去势抵抗性前列腺癌PET成像的临床转化及首次人体应用
Theranostics. 2017 Sep 26;7(18):4359-4369. doi: 10.7150/thno.20586. eCollection 2017.
4
Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.用(44m/44)Sc对DOTA和DOTA肽进行放射性标记的反应条件优化及体内PET发生器可行性的实验证据
Nucl Med Biol. 2014 May;41 Suppl:e36-43. doi: 10.1016/j.nucmedbio.2013.11.004. Epub 2013 Nov 16.
5
Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator system.钪-44:来自(44)钛/(44)钪发生器系统的长寿命正电子发射断层显像(PET)放射性核素的优势
Curr Radiopharm. 2012 Jul;5(3):187-201. doi: 10.2174/1874471011205030187.
6
Cyclotron production of high purity (44m,44)Sc with deuterons from (44)CaCO3 targets.用来自(44)CaCO₃靶的氘核通过回旋加速器生产高纯度(44m,44)Sc。
Nucl Med Biol. 2015 Jun;42(6):524-9. doi: 10.1016/j.nucmedbio.2015.03.002. Epub 2015 Mar 11.
7
Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.回旋加速器生产的 44Sc 作为三价 β-发射体诊断匹配物的承诺:44Sc-DOTA-叶酸缀合物的体外和体内研究。
J Nucl Med. 2013 Dec;54(12):2168-74. doi: 10.2967/jnumed.113.123810. Epub 2013 Nov 6.
8
Separation of Ti from proton irradiated scandium by using solid-phase extraction chromatography and design of Ti/Sc generator system.利用固相萃取色谱法从质子辐照钪中分离钛以及钛/钪发生器系统的设计
J Chromatogr A. 2016 Dec 16;1477:39-46. doi: 10.1016/j.chroma.2016.11.047. Epub 2016 Nov 24.
9
Development of a SnO-based Ti/Sc generator for medical applications.用于医疗应用的基于 SnO 的 Ti/Sc 发生器的开发。
J Chromatogr A. 2024 Sep 13;1732:465245. doi: 10.1016/j.chroma.2024.465245. Epub 2024 Aug 8.
10
Cyclotron Production and Separation of Scandium Radionuclides from Natural Titanium Metal and Titanium Dioxide Targets.回旋加速器生产及从天然钛金属和二氧化钛靶材中分离钪放射性核素。
J Nucl Med. 2021 Jan;62(1):131-136. doi: 10.2967/jnumed.120.242941. Epub 2020 Jul 3.

引用本文的文献

1
Improvement of End-of-Synthesis Radiochemical Purity of Lu-DOTA-PSMA-Ligands with Alternative Synthesis Approaches: Conversion Upswing and Side-Products Minimization.采用替代合成方法提高镥-多胺多羧基配体-前列腺特异性膜抗原配体合成终产物的放射化学纯度:转化率上升及副产物最小化
Pharmaceutics. 2024 Nov 30;16(12):1535. doi: 10.3390/pharmaceutics16121535.
2
Scandium Radioisotopes-Toward New Targets and Imaging Modalities.钪放射性同位素——迈向新的靶点和成像方式。
Molecules. 2023 Nov 19;28(22):7668. doi: 10.3390/molecules28227668.
3
Radiometallation and photo-triggered release of ready-to-inject radiopharmaceuticals from the solid phase.

本文引用的文献

1
Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements.用于诊疗应用的钪放射性核素的生产:迈向质量要求的标准化。
EJNMMI Radiopharm Chem. 2021 May 25;6(1):19. doi: 10.1186/s41181-021-00131-2.
2
Applicability of Internal Standardization with Yttrium to the Solid-phase Extraction of Trace Elements in Groundwater and Wastewater Using an Aminocarboxylic Acid-type Chelating Resin.采用钇内标法测定用氨基羧酸型螯合树脂固相萃取法提取地下水和废水中痕量元素的适用性。
Anal Sci. 2021 Aug 10;37(8):1147-1156. doi: 10.2116/analsci.20P387. Epub 2021 Jan 29.
3
Synthesis and Evaluation of Ga- and Lu-Labeled ()- vs ()-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives.
放射性金属化以及从固相中光触发释放即用型放射性药物。
Chem Sci. 2023 Apr 17;14(19):5038-5050. doi: 10.1039/d2sc06977f. eCollection 2023 May 17.
4
Engineering a modular Ti/Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry.构建模块化钛/钪发生器:临床前模型中的洗脱液评估及人体辐射剂量测定估算
EJNMMI Res. 2023 Feb 28;13(1):17. doi: 10.1186/s13550-023-00968-5.
5
Current State of Ti/Sc Radionuclide Generator Systems and Separation Chemistry.钛/钪放射性核素发生器系统及分离化学的现状。
Curr Radiopharm. 2023;16(2):95-106. doi: 10.2174/1874471016666221111154424.
镓和镥标记的 ()-与 ()-DOTAGA 前列腺特异性膜抗原靶向衍生物的合成与评价。
Mol Pharm. 2020 Dec 7;17(12):4589-4602. doi: 10.1021/acs.molpharmaceut.0c00777. Epub 2020 Oct 27.
4
Image quality analysis of Sc on two preclinical PET scanners: a comparison to Ga.两种临床前正电子发射断层扫描(PET)扫描仪上钪(Sc)的图像质量分析:与镓(Ga)的比较
EJNMMI Phys. 2020 Mar 12;7(1):16. doi: 10.1186/s40658-020-0286-3.
5
Preparation of Zirconium-89 Solutions for Radiopharmaceutical Purposes: Interrelation Between Formulation, Radiochemical Purity, Stability and Biodistribution.用于放射性药物目的的 89Zr 溶液的制备:制剂、放射化学纯度、稳定性和生物分布之间的关系。
Molecules. 2019 Apr 18;24(8):1534. doi: 10.3390/molecules24081534.
6
Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept.用于核医学的有前途的钪放射性核素:生产和化学的综述,直至体内概念验证。
Cancer Biother Radiopharm. 2018 Oct;33(8):316-329. doi: 10.1089/cbr.2018.2485. Epub 2018 Sep 28.
7
Separation of Sc from Natural Calcium Carbonate Targets for Synthesis of Sc-DOTATATE.从天然碳酸钙中分离钪以用于合成 Sc-DOTATATE。
Molecules. 2018 Jul 20;23(7):1787. doi: 10.3390/molecules23071787.
8
Production and separation of Sc for radiopharmaceutical purposes.用于放射性药物目的的钪的生产与分离。
EJNMMI Radiopharm Chem. 2017;2(1):14. doi: 10.1186/s41181-017-0033-9. Epub 2017 Nov 25.
9
Clinical Translation and First In-Human Use of [Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.[钪]Sc-PSMA-617用于转移性去势抵抗性前列腺癌PET成像的临床转化及首次人体应用
Theranostics. 2017 Sep 26;7(18):4359-4369. doi: 10.7150/thno.20586. eCollection 2017.
10
Sc production development by cyclotron irradiation of Ca.通过钙的回旋加速器辐照进行钪的生产开发。 (注:原文中“Sc”是钪的化学符号,“Ca”是钙的化学符号 ,但从专业角度看,此句表述可能不太准确完整,正常可能是在阐述关于钪通过钙相关的回旋加速器辐照来进行生产开发的研究或内容等 )
J Radioanal Nucl Chem. 2017;313(2):429-434. doi: 10.1007/s10967-017-5321-z. Epub 2017 Jun 13.